Humankind Investments’s AdaptHealth AHCO Stock Holding History

Humankind Investments’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,770	Closed	-$225K	–	149
2025 Q1	$225K	Buy	20,770 +2,791	+16%	+$28.1K	0.06%	127
2024 Q4	$171K	Buy	17,979 +2,776	+18%	+$28.1K	0.04%	144
2024 Q3	$171K	Sell	15,203 -544	-3%	-$5.78K	0.06%	136
2024 Q2	$157K	Buy	+15,747	New	+$160K	0.04%	133

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Humankind Investments's AHCO Position: Q2 2025 in Review

Humankind Investments sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 20,770 shares — an estimated $225K sold.

Humankind Investments first reported a position in AHCO in Q2 2024 and held it in 4 quarters. The position peaked at $225K in Q1 2025. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

Humankind Investments reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
Humankind Investments sold 20,770 AdaptHealth shares in Q2 2025, an estimated $225K.
Humankind Investments first reported a position in AdaptHealth in Q2 2024 and held it in 4 quarters.
Humankind Investments's AdaptHealth position peaked at $225K in Q1 2025.
218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Humankind Investments's 13F filing for Q2 2025, filed 14 Aug 2025.